| LncRNA |
Compound |
Cancer |
P-value |
Effect |
| ENSG00000266970.1 |
Cisplatin |
Pancreatic adenocarcinoma |
0.02077436 |
Resistant |
| ENSG00000266970.1 |
Cisplatin |
Thyroid carcinoma |
0.025300923 |
Resistant |
| ENSG00000266970.1 |
Cisplatin |
Bladder urothelial carcinoma |
0.019700669 |
Sensitive |
| ENSG00000266970.1 |
Cisplatin |
Esophageal cancer |
0.033677776 |
Sensitive |
